NVO
USDNovo Nordisk A/S Common Stock
$45.700-0.520 (-1.125%)
实时价格
Healthcare
Drug Manufacturers - General
丹麦
价格图表
Loading Chart...
关键指标
市场指标
开盘价
$46.220
最高价
$46.360
最低价
$45.570
成交量
37.86M
公司基本面
市值
210.1B
所属行业
Drug Manufacturers - General
国家/地区
Denmark
交易统计
平均成交量
15.16M
交易所
NYQ
货币
USD
52周价格范围
最低价 $45.05当前价 $45.700最高价 $112.52
相关新闻
CNBC
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
查看更多
CNBC
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
查看更多
CNBC
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
查看更多
CNBC
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
查看更多
